Descriptor English: | Vaccines, DNA | ||||||
Descriptor Spanish: |
Vacunas de ADN
| ||||||
Descriptor Portuguese: | Vacinas de DNA | ||||||
Descriptor French: | Vaccins à ADN | ||||||
Entry term(s): |
DNA Vaccine DNA Vaccine, Naked DNA Vaccine, Recombinant DNA Vaccines DNA Vaccines, Naked DNA Vaccines, Recombinant Naked DNA Vaccine Naked DNA Vaccines Recombinant DNA Vaccine Recombinant DNA Vaccines Vaccine, DNA Vaccine, Naked DNA Vaccine, Recombinant DNA Vaccines, Naked DNA Vaccines, Recombinant DNA |
||||||
Tree number(s): |
D12.776.828.868.228.250 D20.215.894.865.450.250 D23.050.865.450.250 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D019444 | ||||||
Scope note: | Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism MI microbiology PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine VI virology |
||||||
Previous Indexing: |
Vaccines, Synthetic (1986-1996) |
||||||
DeCS ID: | 33063 | ||||||
Unique ID: | D019444 | ||||||
NLM Classification: | QW 805 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1997/01/01 | ||||||
Date of Entry: | 1996/06/10 | ||||||
Revision Date: | 2020/05/27 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Complex Mixtures [D20]Complex Mixtures -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Vaccines, DNA
- Preferred
Concept UI |
M0028927 |
Scope note | Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers. |
Preferred term | Vaccines, DNA |
Entry term(s) |
DNA Vaccine DNA Vaccine, Naked DNA Vaccine, Recombinant DNA Vaccines DNA Vaccines, Naked DNA Vaccines, Recombinant Naked DNA Vaccine Naked DNA Vaccines Recombinant DNA Vaccine Recombinant DNA Vaccines Vaccine, DNA Vaccine, Naked DNA Vaccine, Recombinant DNA Vaccines, Naked DNA Vaccines, Recombinant DNA |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey